The publisher has released its latest report 'Nigeria - Healthcare, Regulatory and Reimbursement Landscape'. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Nigeria. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.
Nigeria’s pharmaceutical market has high potential and is one of the fastest developing pharmaceutical markets in Africa. The rise in communicable and non-communicable diseases, and government initiatives such as National Drug Policy intended to drive the growth of the Nigerian pharmaceutical market. While inadequate power and water supply, dysfunctional transport system, and under-utilized manufacturing capacity, along with counterfeiting drugs are hindering the development of the healthcare market. Nigeria’s pharmaceutical market, based on pharmaceutical production value, 1.03B in 2014 is expected to increase to $3.24B in 2021 at a Compound Annual Growth Rate (CAGR) of 18%. It is forecast to reach about $5.30B in 2024. The medical devices market of Nigeria was valued at $134.7M in 2018, which is expected to increase to $174.4M in 2021 at a CAGR of 9%. The medical device market is expected to grow at a CAGR of 9% from $174.4M in 2021 to $201.8M in 2023.
The report provides information on the healthcare, regulatory, and reimbursement landscape in Nigeria, and includes:
This report will enhance your decision-making capability by allowing you to:
Nigeria’s pharmaceutical market has high potential and is one of the fastest developing pharmaceutical markets in Africa. The rise in communicable and non-communicable diseases, and government initiatives such as National Drug Policy intended to drive the growth of the Nigerian pharmaceutical market. While inadequate power and water supply, dysfunctional transport system, and under-utilized manufacturing capacity, along with counterfeiting drugs are hindering the development of the healthcare market. Nigeria’s pharmaceutical market, based on pharmaceutical production value, 1.03B in 2014 is expected to increase to $3.24B in 2021 at a Compound Annual Growth Rate (CAGR) of 18%. It is forecast to reach about $5.30B in 2024. The medical devices market of Nigeria was valued at $134.7M in 2018, which is expected to increase to $174.4M in 2021 at a CAGR of 9%. The medical device market is expected to grow at a CAGR of 9% from $174.4M in 2021 to $201.8M in 2023.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Nigeria, and includes:
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Novartis, GlaxoSmithKline, Pfizer, Sanofi, and Fidson.
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, GE Healthcare, and Roche.
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:
- Develop business strategies by understanding the trends shaping and driving Nigerian healthcare market.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Nigerian healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Table of Contents
1 Table of Contents
2. Executive Summary
3. Overview of Pharmaceutical Market
4. Overview of Medical Devices Market
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
6. Deal Analysis
7. HealthTech Landscape
8. Market Access
9. Country Healthcare Landscape
13. Appendix
List of Tables
List of Figures
